Skip to main content

Table 3 Resource utilisation among patients with AGC during follow-up

From: The economic burden of advanced gastric cancer in Taiwan

Resource utilisation

n

Total (n = 118)

BSC (n = 40)

2nd-line TX (n = 78)

Mean follow-up days (SD)

118

397.1 (300.0)

[Median: 291.5]

296.9 (228.6)

[Median: 211.5]

448.5 (320.0)

[Median: 326.5]

Inpatient stay (days), mean(SD)

 Overnight inpatient stay

118

19.6 (22.5)

17.9 (26.0)

20.5 (20.6)

 Hospice unit stay

99

2.4 (5.1)

2.0 (3.2)

2.6 (5.9)

 Skilled nursing facility stay

96

2.4 (20.4)

7.2 (36.4)

0.2 (1.1)

 Oncology-oriented inpatient a rehabilitation clinic stay a

96

7.5 (18.0)

12.5 (25.1)

5.2 (13.3)

Total

94

29.0 (37.3)

34.8 (52.2)

26.4 (28.4)

Outpatient visits (visits), mean(SD)

 Outpatient clinic visits

86

19.6 (14.0)

19.1 (16.9)

19.8 (13.0)

 Nutritional support visits

104

1.3 (2.2)

1.4 (1.4)

1.3 (2.5)

 Home visits

97

0.7 (1.8)

0.7 (1.0)

0.7 (2.1)

Total

84

21.1 (15.4)

19.9 (17.6)

21.4 (14.7)

  1. Abbreviations: AGC Advanced Gastric Cancer, BSC Best Supportive Care, SD Standard Deviation, TX treatment
  2. aBoth parametric and non-parametric tests indicated no statistically significant differences in resource utilisation between patients with BSC and patients with second-line treatment following the first-line treatment, except for skilled nursing facility stay (Mann-Whitney test p-value = 0.019). [Also in oncology-oriented inpatient rehabilitation clinic visits at p < 0.1 (t-test p-value = 0.066, Mann-Whitney p-value = 0.061)